Inhalte im Video:

00:00

Diabetes, hyperlipidemia, obesity, cardiovascular disease, chronic kidney disease: Some of these diseases predispose to gout, and gout in turn predisposes to some of those conditions.

01:05

The effects of urate lowering on comorbidities

01:33

Allopurinol or Febuxostat – which one is better in terms of comorbidities? Do Febuxostat or Febuxostat discontinuation lead to cardiovascular events?

03:09

Evidence and cost-effectiveness for urate-lowering in persons without manifest gout

03:48

If and how high uric acid levels might be protective against neurodegenerative diseases.

Interview mit:

Dr. Edward Roddy

Interview von:

Produziert von:

Christophe Vandenbussche

14. Juni 2019Dr. Edward Roddy

EULAR 2019: Comorbidities in Gout – innocent bystanders no more

Dr. Edward Roddy from Keele University, UK, about connections between uric acid levels and cardiovascular disease or chronic kidney disease, and whether gout is beneficial for the brain.